Dr Reddys Laboratories Ltd has informed BSE that pursuant to Dr. Reddy’s Employees ADR Stock Option Scheme, 2007, the Compensation Committee of the Board of Directors of the Company has allotted 15,970 ADRs of Rs 5 each of the Company on July 02, 2008, to US Employees of the Company who have exercised their ADR Stock Options.
Dr Reddys Laboratories Ltd has informed BSE that pursuant to Dr. Reddy’s Employees Stock Option Scheme, 2002, the Compensation Committee of the Board of Directors of the Company has allotted 93,297 equity shares of Rs 5 each of the Company on June 17, 2008, to Directors / Employees who have exercised their Stock Options.
Dr Reddys Laboratories Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from July 08, 2008 to July 12, 2008 (both days inclusive) for the purpose of payment of dividend & Annual General Meeting (AGM) of the Company to be held on July 22, 2008.
Dr Reddys Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 20, 2008, inter alia, has approved the following:
1. Mr. P N Devarjan ceased to be the Director of the Company effective as on date.
2. The Compensation Committee approved grant of 407,220 stock options at par value to the employees of the Company.
3. The Board of Directors approved grant of 18,000 stock options at par value to the Independent Directors of the Company.
4. The Board of Directors based on the recommendation of the Compensation Committee proposed for an amendment in the existing schemes of stock options subject to the shareholders approval.
Dr Reddys Laboratories Ltd has announced the following results for the quarter & year ended March 31, 2008:
The Unaudited results for the Quarter ended March 31, 2008
The Company has posted a net profit of Rs 1622.60 million for the quarter ended March 31, 2008 as compared to Rs 2689.00 million for the quarter ended March 31, 2007. Total Income has decreased from Rs 11510.60 million for the quarter ended March 31, 2007 to Rs 10384.70 million for the quarter ended March 31, 2008.
The Audited results for the Year ended March 31, 2008
The Company has posted a net profit of Rs 4752.20 million for the year ended March 31, 2008 as compared to Rs 11768.60 million for the year ended March 31, 2007. Total Income has decreased from Rs 40843.10 million for the year ended March 31, 2007 to Rs 35850.10 million for the year ended March 31, 2008.
The Consolidated results are as follows:
The Audited consolidated results for the Year ended March 31, 2008
The Group has posted a net profit attributable to the shareholders of the parent of Rs 4381.30 million for the year ended March 31, 2008 as compared to Rs 9658.90 million for the year ended March 31, 2007. Total Income has decreased from Rs 66417.60 million for the year ended March 31, 2007 to Rs 51954.50 million for the year ended March 31, 2008.
The Unaudited Consolidated results as per US GAAP are as follows:
The Group has posted a net profit of Rs 4678.042 million (USD 116.893 million) for the year ended March 31, 2008 as compared to Rs 9326.838 million for the year ended March 31, 2007. Revenues has decreased from Rs 65095.092 million for the year ended March 31, 2007 to Rs 50005.626 million (USD 1249.516 million) for the year ended March 31, 2008.
The figures for year ended March 31, 2007 consolidated results as per US GAAP are Audited.
Dr Reddys Laboratories Ltd has informed BSE that pursuant to Dr. Reddy’s Employees Stock Option Scheme, 2002, the Compensation Committee of the Company has allotted 2,870 equity shares of Rs 5 each of the Company on May 03, 2008, to Employees who have exercised their Stock Options.
Pursuant to Dr. Reddy’s Employees ADR Stock Option Scheme, 2007, the Compensation Committee of the Board of Directors of the Company has allotted 17,604 ADRs of Rs 5 each of the Company on May 03, 2008, to US Employees of the Company who have exercised their ADR Stock Options.
Dr Reddys Laboratories Ltd has informed BSE that pursuant to Dr. Reddy’s Employees Stock Option Scheme, 2002, the Compensation Committee of the Board of Directors of the Company has allotted 37,094 equity shares of Rs 5 each of the Company on February 21, 2008, to Employees who have exercised their Stock Options.